In this exploratory analysis from the population-based STHLM3 study [13], we have addressed how well PSA, PSA density, and the novel Stockholm3 blood test can identify the subset of men with prostate cancer among those with at least moderate LUTS. The gene discussed is KLK3; the disease is Familial prostate cancer.